Business FEATURED Markets

Sorrento Therapeutics Inc (NASDAQ:SRNE) Rejected an Unsolicited Acquisition Proposal

Sorrento Therapeutics Inc (NASDAQ:SRNE) said on Monday that it had rejected an unsolicited acquisition proposal from the two pharmaceutical companies, saying it significantly undervalued the drugmaker and was not in best interests of its stockholders.   The buyout is all-cash deal on Saturday, offered between $3 and $5 for each of Sorrento Therapeutics’s outstanding shares, […]